Note: Ingredients listed on restricted chemical lists
EC/CAS
203-157-5/103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
238-877-9/14807-96-6
Name of the chemical
Talc
Concentration
1 - 2
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
1-2
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
022-006-
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
<0.5
General Information
Revision date
2022-02-10
Product name
PANADOL NIGHT TABLETS
Product Synonyms
PANADOL NIGHT TABLETS (ANZ) * PANADOL NIGHT CAPLETS (ANZ) * PANADOL NIGHT
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H411
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Acute toxicity, oral Category 4 H302 - Harmful if swallowed.
Environmental hazards
Hazardous to the aquatic environment, Category 2 H411 - Toxic to aquatic life with long-term aquatic hazard long lasting effects. Hazard summary Caution - Pharmaceutical agent. Harmful if swallowed. Dangerous for the environment if discharged into watercourses. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
DIPHENHYDRAMINE HYDROCHLORIDE, HYDROXYPROPYL METHYL CELLULOSE, PARACETAMOL, Polyvinylpyrrolidone, Talc, Titanium dioxide
Signal word
Warning
Hazard statements
H302 Harmful if swallowed. H411 Toxic to aquatic life with long lasting effects.
Prevention
P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment.
Response
P301 + P312 IF SWALLOWED: Call a POISON CENTRE/doctor/ if you feel unwell. P330 Rinse mouth. P391 Collect spillage.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
11.4 % of the mixture consists of component(s) of unknown acute oral toxicity. 95.56 % of the mixture consists of component(s) of unknown acute dermal toxicity. 12.6 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 12.6 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. This mixture does not contain substances assessed to be vPvB / PBT according to Regulation (EC) No 1907/2006, Annex XIII. The product does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. See section 11 of the SDS for additional information on health hazards.
